excipients

Isomalt (Palatinitol) is a mixture of 1,6-mannitol glucopyranoside and 1,6-sorbitol glucopyranoside

Poly Vinyl Alcohol (Polyvinyl alcohol) is a biodegradable and wound-healing polymer used in a wide range of biomedical applications.Poly Vinyl Alcohol is commonly used in the manufacture of medical excipients.

Poly(acrylic acid) serves as an effective corrosion inhibitor for pure cast aluminium in acidic environments through its adsorption onto the metal's surface. Additionally, this compound functions as an excipient within the pharmaceutical industry, utilized in roles such as a coating material and release blocker. Pharmaceutical excipients, also known as pharmaceutical auxiliaries, are chemical substances employed in drug formulation alongside the active pharmaceutical ingredients to enhance the stability, solubility, and manufacturability of the products. These excipients also influence the absorption, distribution, metabolism, and elimination (ADME) processes of drugs [1] [2].

Cellulose can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs [1] .

Maltodextrin (dextrose equivalent 16.5-19.5) serves as an excipient in pharmaceutical applications. Excipients, also known as pharmaceutical auxiliaries, are chemical substances utilized in drug formulation alongside active pharmaceutical ingredients. They primarily enhance the stability, solubility, and processability of drug preparations, while also influencing the absorption, distribution, metabolism, and elimination (ADME) of co-administered drugs [1].

Trisodium phosphate dodecahydrate serves as a corrosion inhibitor for iron in 0.1 M NaClO4 solutions, effective under both aerated and deaerated conditions. Additionally, it acts as an excipient in pharmaceutical formulations, functioning primarily as a pH regulator and buffer. These excipients, also known as pharmaceutical auxiliaries, are substances utilized in the pharmaceutical manufacturing process besides the active pharmaceutical ingredients. They are crucial for enhancing the stability, solubility, and processability of pharmaceutical products. Moreover, pharmaceutical excipients play a significant role in influencing the absorption, distribution, metabolism, and elimination (ADME) of co-administered drugs, thereby affecting their efficacy and safety [1] [2].

Peginterferon α-2a (PEG-IFN α2a) exhibits inhibitory effects on chronic hepatitis B and C. Its formulation includes excipients such as sodium chloride, benzyl alcohol, polysorbate 80, acetic acid, sodium acetate, and water for injection.

Undecyl 8-bromooctanoate is a type of phospholipid known for its excellent biocompatibility and significant amphiphilic properties. These characteristics make phospholipids ideal and suitable as key drug formulations or excipients, enhancing therapeutic outcomes. Undecyl 8-bromooctanoate is applicable in research on drug delivery.

PVA (Mw 67000, 87-89% hydrolyzed, ～1400 polymerization) is a form of polyvinyl alcohol with a molecular weight of 67000 and hydrolytic properties. The degree of hydrolysis indicates the rate at which acetate groups in the original polyvinyl acetate are converted to hydroxyl groups. This PVA is obtained by polymerizing vinyl acetate and subsequently removing the acetate groups through hydrolysis. Polyvinyl alcohols with varying degrees of hydrolysis can be used in self-crosslinking to form freeze gels, which are utilized as biological excipients.

DPPE-PEG-amine (MW 2000) is a type of phospholipid. Phospholipids possess excellent biocompatibility and distinct amphiphilic properties, making them suitable and prominent excipients or formulations in drug delivery for enhancing therapeutic outcomes. DPPE-PEG-amine (MW 2000) is applicable in studies related to drug delivery.

DSPE-Hyd-PEG-Mal (MW 2000) is a phospholipid. With excellent biocompatibility and significant amphiphilic properties, phospholipids are ideal as primary formulations or excipients in drug formulations, leading to enhanced therapeutic outcomes. DSPE-Hyd-PEG-Mal (MW 2000) is applicable in drug delivery research.

1,2-Dioleoyl-sn-glycero-3-PA (ammonium) is a phospholipid. With excellent biocompatibility and notable amphiphilic properties, phospholipids serve as the principal and suitable dosage forms or excipients in drug formulations, enabling enhanced therapeutic efficacy. 1,2-Dioleoyl-sn-glycero-3-PA (ammonium) is applicable in drug delivery research.

DOPE-PEG-COOH (MW 5000) is a phospholipid. With excellent biocompatibility and significant amphiphilic properties, phospholipids are ideal for use as primary carriers or excipients in drug formulations, enhancing therapeutic effectiveness. DOPE-PEG-COOH (MW 5000) is suitable for research in drug delivery.

PVA (Mw 125000, 98-99% hydrolyzed, ～2800 polymerization) is polyvinyl alcohol with a molecular weight of 125000 and has hydrolytic properties. The degree of hydrolysis refers to the conversion percentage of acetyl groups in the original polyvinyl acetate to hydroxyl groups. PVA of this specification is derived from the hydrolysis of polyvinyl acetate after polymerization, removing acetyl groups to yield polyvinyl alcohol. PVA with varying degrees of hydrolysis can be used in self-crosslinking formulations to create freeze gels, which serve as biological excipients.

PVA (Mw 27000, 98-99% hydrolyzed, ～600 polymerization) is a polyvinyl alcohol with a molecular weight of 27000, characterized by its hydrolyzed nature. The degree of hydrolysis indicates the conversion rate of acetate groups to hydroxyl groups from the original polyvinyl acetate. PVA is produced by polymerizing vinyl acetate and subsequently hydrolyzing to remove acetate groups, yielding polyvinyl alcohol. Polyvinyl alcohol with various degrees of hydrolysis can be used for self-crosslinking to form cryogels, applied as biological excipients.

PEG6000 is used as a pharmaceutical excipient, such as in ointment bases and lubricants. Pharmaceutical excipients, or adjuvants, are chemical substances used in the pharmaceutical process excluding active drug components. They generally refer to the inactive components in drug formulations that enhance the stability, solubility, and manufacturability of the drug. Excipients also impact the absorption, distribution, metabolism, and elimination (ADME) processes of combined medications.

PEG600 can serve as an ointment base and lubricant, among other pharmaceutical excipients. These excipients or adjuvants are chemical substances used in the drug manufacturing process that are not active medicinal ingredients. They typically enhance the stability, solubility, and manufacturability of pharmaceutical formulations, while also influencing the absorption, distribution, metabolism, and excretion (ADME) of combined medications.

PEG1000 can be utilized as a pharmaceutical excipient in applications such as ointment bases and lubricants. Pharmaceutical excipients or adjuvants refer to chemical substances used in the pharmaceutical manufacturing process, excluding the active drug components. Generally, they are non-active constituents in drug formulations that enhance stability, solubility, and processability. Additionally, excipients can influence the absorption, distribution, metabolism, and excretion (ADME) processes during concurrent medication use.

PEG1500 serves as an ointment base and lubricant, functioning as a pharmaceutical excipient. Pharmaceutical excipients or adjuvants are defined as chemical substances used in the drug formulation process apart from the active pharmaceutical ingredients. These excipients typically are inactive components that enhance the stability, solubility, and processing of drug formulations. Additionally, pharmaceutical excipients can impact the absorption, distribution, metabolism, and excretion (ADME) processes when drugs are administered together.

PEG4000 can be utilized as a pharmaceutical excipient, such as in ointment bases and lubricants. Pharmaceutical excipients, also known as auxiliary agents, are chemical substances used in the manufacturing of pharmaceuticals that are not the active drug components. They generally refer to inactive ingredients in drug formulations that enhance stability, solubility, and processability. Furthermore, excipients can affect the absorption, distribution, metabolism, and elimination (ADME) of co-administered drugs.

Maltodextrin, dextrose equivalent 16.5-19.5 (Standard) is the standard substance of Maltodextrin, dextrose equivalent 16.5-19.5, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Maltodextrin (dextrose equivalent 16.5-19.5) serves as an excipient in pharmaceutical applications. Excipients, also known as pharmaceutical auxiliaries, are chemical substances utilized in drug formulation alongside active pharmaceutical ingredients. They primarily enhance the stability, solubility, and processability of drug preparations, while also influencing the absorption, distribution, metabolism, and elimination (ADME) of co-administered drugs .

Maltodextrin, with a dextrose equivalent (DE) of 5.0-8.0, can be utilized as an excipient in pharmaceuticals. Excipients, also known as auxiliary agents, are chemical substances employed in drug formulation to support the active ingredients. Typically, they are non-active components that enhance the stability, solubility, and manufacturability of the drug formulation. Additionally, excipients can impact the absorption, distribution, metabolism, and elimination (ADME) processes of combined medications. The DE value indicates the number of reducing-end aldehyde groups relative to pure glucose at the same concentration; hence, a higher DE signifies a higher rate of hydrolysis conversion and a lower average molecular weight.